Cabot (NYSE:CBT – Get Free Report) is set to issue its quarterly earnings data after the market closes on Monday, November 4th. Analysts expect the company to announce earnings of $1.82 per share for the quarter. Cabot has set its FY24 guidance at $7.00-$7.10 EPS.Persons interested in listening to the company’s earnings conference call can do so using this link.
Cabot (NYSE:CBT – Get Free Report) last released its earnings results on Monday, August 5th. The specialty chemicals company reported $1.92 EPS for the quarter, topping the consensus estimate of $1.72 by $0.20. Cabot had a return on equity of 26.99% and a net margin of 12.05%. The business had revenue of $1.02 billion during the quarter, compared to analysts’ expectations of $1 billion. During the same quarter last year, the firm posted $1.42 earnings per share. The firm’s revenue was up 5.0% on a year-over-year basis. On average, analysts expect Cabot to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.
Cabot Price Performance
Cabot stock opened at $109.26 on Monday. The stock’s 50 day moving average price is $107.40 and its two-hundred day moving average price is $100.31. The stock has a market capitalization of $6.04 billion, a price-to-earnings ratio of 13.83, a PEG ratio of 0.93 and a beta of 1.19. The company has a debt-to-equity ratio of 0.72, a quick ratio of 1.45 and a current ratio of 2.22. Cabot has a 52-week low of $65.10 and a 52-week high of $117.14.
Analysts Set New Price Targets
View Our Latest Research Report on CBT
Insider Transactions at Cabot
In related news, CEO Sean D. Keohane sold 25,617 shares of the firm’s stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $101.55, for a total value of $2,601,406.35. Following the transaction, the chief executive officer now owns 331,174 shares of the company’s stock, valued at approximately $33,630,719.70. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other Cabot news, CEO Sean D. Keohane sold 25,617 shares of the firm’s stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $101.55, for a total transaction of $2,601,406.35. Following the transaction, the chief executive officer now directly owns 331,174 shares in the company, valued at approximately $33,630,719.70. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Erica Mclaughlin sold 23,274 shares of the company’s stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $99.79, for a total transaction of $2,322,512.46. Following the completion of the sale, the chief financial officer now owns 59,814 shares of the company’s stock, valued at approximately $5,968,839.06. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 71,939 shares of company stock valued at $7,308,812 over the last three months. Corporate insiders own 3.07% of the company’s stock.
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Featured Stories
- Five stocks we like better than Cabot
- How Can Investors Benefit From After-Hours Trading
- Real Estate Sector Outperforms: 3 Stocks to Gain Exposure
- What is a Bond Market Holiday? How to Invest and Trade
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
- The Risks of Owning Bonds
- PureCycle: Up 250% in 2024 – Is This Materials Stock Still a Buy?
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.